Cited by 2,205Malaria Research and ControlPhytochemical compounds biological activitiesBird parasitology and diseases

Spread of Artemisinin Resistance in Plasmodium falciparum Malaria

Open access
Ashley, Elizabeth A., Dhorda, Mehul, Fairhurst, Rick M., Amaratunga, Chanaki, Lim, Parath, Suon, Seila, Sreng, Sokunthea, Anderson, Jennifer M. +75 more·2014·New England Journal of Medicine

Abstract

BACKGROUND: Artemisinin resistance in Plasmodium falciparum has emerged in Southeast Asia and now poses a threat to the control and elimination of malaria. Mapping the geographic extent of resistance is essential for planning containment and elimination strategies. METHODS: Between May 2011 and April 2013, we enrolled 1241 adults and children with acute, uncomplicated falciparum malaria in an open-label trial at 15 sites in 10 countries (7 in Asia and 3 in Africa). Patients received artesunate, administered orally at a daily dose of either 2 mg per kilogram of body weight per day or 4 mg per kilogram, for 3 days, followed by a standard 3-day course of artemisinin-based combination therapy. Parasite counts in peripheral-blood samples were measured every 6 hours, and the parasite clearance half-lives were determined. RESULTS: The median parasite clearance half-lives ranged from 1.9 hours in the Democratic Republic of Congo to 7.0 hours at the Thailand-Cambodia border. Slowly clearing infections (parasite clearance half-life >5 hours), strongly associated with single point mutations in the "propeller" region of the P. falciparum kelch protein gene on chromosome 13 (kelch13), were detected throughout mainland Southeast Asia from southern Vietnam to central Myanmar. The incidence of pretreatment and post-treatment gametocytemia was higher among patients with slow parasite clearance, suggesting greater potential for transmission. In western Cambodia, where artemisinin-based combination therapies are failing, the 6-day course of antimalarial therapy was associated with a cure rate of 97.7% (95% confidence interval, 90.9 to 99.4) at 42 days. CONCLUSIONS: Artemisinin resistance to P. falciparum, which is now prevalent across mainland Southeast Asia, is associated with mutations in kelch13. Prolonged courses of artemisinin-based combination therapies are currently efficacious in areas where standard 3-day treatments are failing. (Funded by the U.K. Department of International Development and others; ClinicalTrials.gov number, NCT01350856.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1314981

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Treatment of malaria in pregnancy has been a major priority for preventing poor pregnancy outcomes worldwide, but the Thailand-Myanmar border region faces unique challenges due to high rates of P. falciparum multi drug resistance and the lack of a safe, radical cure that eliminates dormant P. vivax from the liver in pregnancy.

    “Treatment of malaria in pregnancy has been a major priority for preventing poor pregnancy outcomes worldwide, but the Thailand-Myanmar border region faces unique challenges due to high rates of P. falciparum multi drug resistance [33] and the lack of a safe, radical cure that eliminates dormant P. vivax from the liver in pregnancy [34].”

    From Distance matters: barriers to antenatal care and safe childbirth in a migrant population on the Thailand-Myanmar border from 2007 to 2015, a pregnancy cohort study (2021) · cites this paper as [33]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., Sopha, C., Chuor, C. M., Nguon, C., Sovannaroth, S., Pukrittayakamee, S., Jittamala, P., Chotivanich, K., Chutasmit, K., Suchatsoonthorn, C., Runcharoen, R., Hien, T. T., Thuy-Nhien, N. T., Thanh, N. V., Phu, N. H., Htut, Y., Han, K.-T., Aye, K. H., Mokuolu, O. A., Olaosebikan, R. R., Folaranmi, O. O., Mayxay, M., Khanthavong, M., Hongvanthong, B., Newton, P. N., Onyamboko, M. A., Fanello, C. I., Tshefu, A. K., Mishra, N., Valecha, N., Phyo, A. P., Nosten, F., Yi, P., Tripura, R., Borrmann, S., Bashraheil, M., Peshu, J., Faiz, M. A., Ghose, A., Hossain, M. A., Samad, R., Rahman, M. R., Hasan, M. M., Islam, A., Miotto, O., Amato, R., MacInnis, B., Stalker, J., Kwiatkowski, D. P., Bozdech, Z., Jeeyapant, A., Cheah, P. Y., Sakulthaew, T., Chalk, J., Intharabut, B., Silamut, K., Lee, S. J., Vihokhern, B., Kunasol, C., Imwong, M., Tarning, J., Taylor, W. J., Yeung, S., Woodrow, C. J., Flegg, J. A., Das, D., Smith, J., Venkatesan, M., Plowe, C. V., Stepniewska, K., Guerin, P. J., Dondorp, A. M., Day, N. P., & White, N. J.
Affiliations
  • University of Oxford (GB)
  • University of Maryland, Baltimore (US)
  • National Institutes of Health (US)
  • Cambodia National Malaria Center (KH)
  • Mahidol University (TH)
  • Hospital for Tropical Diseases (GB)
  • University of Ilorin Teaching Hospital (NG)
  • University of Ilorin (NG)
  • Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LA)
  • Ecole de santé publique de Kinshasa (CD)
  • Indian Council of Medical Research (IN)
  • Kenya Medical Research Institute (KE)
  • University of Tübingen (DE)
  • Chittagong Medical College (BD)
  • Wellcome Sanger Institute (GB)
  • Centre for Human Genetics (GB)
  • Nanyang Technological University (SG)
  • London School of Hygiene & Tropical Medicine (GB)
Venue
New England Journal of Medicine
Published
2014-07-31
Volume
371
Issue
5
Pages
411-423
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2171102256
Cited by
2,205
References
32
Citations by year
2026: 97 · 2025: 115 · 2024: 140 · 2023: 134 · 2022: 170 · 2021: 224 · 2020: 219 · 2019: 191 · 2018: 212 · 2017: 222 · 2016: 248 · 2015: 185 · 2014: 42 · 2012: 1
FWCI
230.81
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • DR-NTU (Nanyang Technological University) (submittedVersion)
Funders
  • Bill and Melinda Gates Foundation
  • Sigma-Tau Pharmaceuticals
  • Wellcome Trust (077166, 090770, 090532, 093956, 093956/Z/10/Z)
  • University of Oxford
  • Department for International Development
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phytochemical compounds biological activities
  • Life Sciences › Immunology and Microbiology › Parasitology › Bird parasitology and diseases
Keywords
artemisinin resistance, Plasmodium falciparum, falciparum malaria, kelch13, parasite clearance half-life, artesunate, artemisinin-based combination therapy, drug resistance spread, Southeast Asia, gametocytaemia, malaria elimination
MeSH terms
Adolescent, Adult, Antimalarials, Asia, Southeastern, Child, Child, Preschool, Drug Resistance, Humans, Infant, Middle Aged, Plasmodium falciparum, Protozoan Proteins, Multivariate Analysis, Malaria, Falciparum, Point Mutation, Africa South of the Sahara, Parasitemia, Artemisinins, Young Adult, Parasite Load

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review